Hovedindeksen (OSEBX.OL)

Cours de clôture: 1 456.43 (+4.20), 25. avr 2025
Conclusion légèrement négative

Bas risk

Automatic technical analysis. Moyen terme, 25. avr 2025

Hovedindeksen a débordé du canal haussier à la baisse. Cela indique dans un premier temps, un taux de croissance plus faible ou le début d'un développement plus horizontal. L'indice teste la résistance à environ 1460 points, ce qui peut résulter en une correction. La balance des volumes est négative et affaiblit la valeur sur le court terme. L'indice est généralement considéré comme légèrement negatif technique pour moyen long terme.

Recommendation one to six months: Conclusion légèrement négative (Score: -45)

Période  
Vol.bal. Volatilité Liquidité +/- %
1 jour-0.60%5 746.48+0.29%
5 jours-36.312.02%5 034.03+0.67%
22 jours-56.104.85%5 910.88-5.08%
66 jours-39.488.41%6 429.94-2.33%

More analyses of Hovedindeksen

chart Hovedindeksen (OSEBX) Chandeliers 22 Days
Candlesticks
chart Hovedindeksen (OSEBX) Court terme
Court terme: Négatif
chart Hovedindeksen (OSEBX) Moyen terme
Moyen terme: Conclusion légèrement négative
chart Hovedindeksen (OSEBX) Long terme
Long terme : Hold
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Informasjonskapsler

Vi benytter informasjonskapsler (cookies) for å gi deg en bedre brukeropplevelse. Hvis du fortsetter å bruke nettstedet, aksepterer du dette. Du kan lese mer om vår bruk av informasjonskapsler her.